ID: ALA1801796

Max Phase: Preclinical

Molecular Formula: C13H10INO2

Molecular Weight: 339.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccccc1)c1cc(I)ccc1O

Standard InChI:  InChI=1S/C13H10INO2/c14-9-6-7-12(16)11(8-9)13(17)15-10-4-2-1-3-5-10/h1-8,16H,(H,15,17)

Standard InChI Key:  OGEXIPVUPBXZGK-UHFFFAOYSA-N

Associated Targets(non-human)

Onchocerca ochengi 683 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 339.13Molecular Weight (Monoisotopic): 338.9756AlogP: 3.25#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.50CX Basic pKa: CX LogP: 3.69CX LogD: 3.44
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.83Np Likeness Score: -1.46

References

1. Garner AL, Gloeckner C, Tricoche N, Zakhari JS, Samje M, Cho-Ngwa F, Lustigman S, Janda KD..  (2011)  Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulus.,  54  (11): [PMID:21534605] [10.1021/jm200364n]

Source